Literature DB >> 19577640

Oxidative stress in the pathogenesis of psoriasis.

Qiang Zhou1, Ulrich Mrowietz, Martin Rostami-Yazdi.   

Abstract

Psoriasis is a chronic immune-mediated hyperproliferative inflammatory skin disease in which a cytokine network concept is well established. Skin is a major target of oxidative stress mainly due to reactive oxygen species (ROS) originating from the environment and skin metabolism itself. Although endogenous antioxidants attenuate the harmful effects of ROS, increased or prolonged presence of free radicals can override ROS defense mechanisms and mediate numerous cellular responses that contribute to the development of a variety of skin disorders, including psoriasis. Regarding psoriasis, antioxidant strategies have proven to be beneficial therapeutics. The cellular signaling pathways such as mitogen-activated protein kinase/activator protein 1, nuclear factor kappaB, and Janus kinase-signal transducers and activators of transcription are known to be redox sensitive and proven to be involved in the progress of psoriasis. This review summarizes the current knowledge of the role of the redox system in regulating these signaling pathways related to the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577640     DOI: 10.1016/j.freeradbiomed.2009.06.033

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  67 in total

1.  SIRT1 activity is decreased in lesional psoriatic skin.

Authors:  Matteo Becatti; Victoria Barygina; Giacomo Emmi; Elena Silvestri; Niccolò Taddei; Torello Lotti; Claudia Fiorillo
Journal:  Intern Emerg Med       Date:  2016-06-10       Impact factor: 3.397

2.  Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.

Authors:  Shyam Kishor Sah; Kyung Ho Park; Chae-Ok Yun; Kyung-Sun Kang; Tae-Yoon Kim
Journal:  Antioxid Redox Signal       Date:  2015-11-18       Impact factor: 8.401

3.  Aquaporin-3-mediated hydrogen peroxide transport is required for NF-κB signalling in keratinocytes and development of psoriasis.

Authors:  Mariko Hara-Chikuma; Hiroki Satooka; Sachiko Watanabe; Tetsuya Honda; Yoshiki Miyachi; Takeshi Watanabe; A S Verkman
Journal:  Nat Commun       Date:  2015-06-23       Impact factor: 14.919

Review 4.  Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Authors:  Giulia Ganzetti; Anna Campanati; Elisa Molinelli; Annamaria Offidani
Journal:  World J Cardiol       Date:  2016-02-26

5.  Anti-Psoriatic Drug Monomethylfumarate Increases Nuclear Factor Erythroid 2-Related Factor 2 Levels and Induces Aquaporin-3 mRNA and Protein Expression.

Authors:  Inas Helwa; Vivek Choudhary; Xunsheng Chen; Ismail Kaddour-Djebbar; Wendy B Bollag
Journal:  J Pharmacol Exp Ther       Date:  2017-05-17       Impact factor: 4.030

Review 6.  Bench approaches to study the detrimental cutaneous impact of tropospheric ozone.

Authors:  Benedetta Petracca; Barbara Rothen-Rutishauser; Giuseppe Valacchi; Marc Eeman
Journal:  J Expo Sci Environ Epidemiol       Date:  2020-10-30       Impact factor: 5.563

7.  Impact of depressive symptoms on oxidative stress in patients with psoriasis.

Authors:  Fatih Karababa; Yavuz Yesilova; Enver Turan; Salih Selek; Hacer Altun; Sahabettin Selek
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

Review 8.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

9.  Relationship Between the Serum Total Bilirubin and Inflammation in Patients With Psoriasis Vulgaris.

Authors:  Zhen-Xing Zhou; Jian-Kui Chen; Yan-Ying Hong; Ru Zhou; Dong-Mei Zhou; Li-Yun Sun; Wen-Li Qin; Tian-Cheng Wang
Journal:  J Clin Lab Anal       Date:  2016-04-07       Impact factor: 2.352

10.  Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy.

Authors:  V V Barygina; M Becatti; G Soldi; F Prignano; T Lotti; P Nassi; D Wright; N Taddei; C Fiorillo
Journal:  Redox Rep       Date:  2013-04-19       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.